Pharma Partnerships Sanofi and Pfizer collaborations show strong pharma demand for adaptive immune profiling and MRD data. Growth opportunity to add more pharma clients through co development of companion diagnostics, trial analytics, and integrated data delivery for oncology programs.

IT Integration A tech stack with Cerner, Azure Databricks and Kubernetes enables scalable data workflows. Target health systems and CROs by offering seamless data integration, clinician dashboards, and cloud analytics for MRD and immune profiling results.

Oncology MRD Growth Leadership in clonoSEQ MRD testing supports expansion into lymphoid cancers and broader cancer monitoring. Sell expanded MRD panels, multi site trial support, and post treatment monitoring services to hospitals, cancer centers and life sciences partners.

Revenue & Licensing Steady revenue and modest funding cushion productization and geographic expansion. Consider enterprise licensing, data licensing collaborations, and tiered pricing for pharma and research customers to scale revenue.

Market Momentum Active conference participation and high profile partnerships strengthen competitive positioning. Leverage momentum to win larger multi center studies, strategic collaborations and data driven immune medicine programs with pharma and academic partners.